Perfluorocarbons: new tool for islets preservation in vitro.

Area of Science:

• Biomedical Engineering
• Transplantation Immunology
• Cell Biology

Background:

• Pancreatic islet transplantation is a promising treatment for type 1 diabetes.
• Transplant failure is often linked to hypoxia and extracellular matrix (ECM) disruption.
• Perfluorocarbons (PFCs) are known for high oxygen solubility and anti-adhesive properties.

Purpose of the Study:

• To evaluate the impact of PFCs on islet viability, functionality, and ECM integrity.
• To investigate PFCs' potential role in preventing adhesion-related ECM disruption in islets.

Main Methods:

• Rat islets were cultured for 24 hours with or without 3.5% PFCs.
• Islet viability was assessed using FDA/PI staining.
• Insulin secretion was measured via stimulation index (ELISA).
• Insulin and laminin mRNA expression and protein levels were analyzed using RT-PCR and immunostaining.

Main Results:

• Islet viability remained high (approx. 80%) in both PFC-treated and control groups.
• PFC treatment significantly improved islet functionality, indicated by a higher stimulation index (4.9 vs. 2.8).
• Laminin mRNA expression was reduced by 55% in PFC-treated islets, and ECM preservation was observed via immunohistochemistry.

Conclusions:

• PFCs effectively preserve pancreatic islet viability and functionality in vitro.
• PFCs mitigate ECM disruption by inhibiting adhesion, suggesting a protective role.
• PFCs represent a potential new tool for improving islet preservation strategies in transplantation.